These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2119871)

  • 1. Ionic versus nonionic contrast media: a burden or a bargain?
    Gafni A; Zylak CJ
    CMAJ; 1990 Sep; 143(6):475-8. PubMed ID: 2119871
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonionic contrast media: a bargain for some, a burden for many.
    Goel V; Deber RB; Detsky AS
    CMAJ; 1990 Sep; 143(6):480-1. PubMed ID: 2119872
    [No Abstract]   [Full Text] [Related]  

  • 3. Ionic versus nonionic contrast media: a burden or a bargain?
    Kalant N
    CMAJ; 1991 Jan; 144(2):123-4, 128. PubMed ID: 1898868
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of quality-adjusted life years (QALYs) in the economic appraisal of health care.
    Kawachi I; Bethwaite P; Bethwaite J
    N Z Med J; 1990 Feb; 103(883):46-8. PubMed ID: 2106105
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonionic contrast media: economic analysis and health policy development.
    Goel V; Deber RB; Detsky AS
    CMAJ; 1989 Feb; 140(4):389-95. PubMed ID: 2492446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug and health outcomes measurement in clinical practice.
    Ibern P
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():45-6. PubMed ID: 9800730
    [No Abstract]   [Full Text] [Related]  

  • 7. The last third. R&D: the return on our investment.
    Tsuchiyama S
    Adm Radiol; 1991 Jan; 10(1):22-5. PubMed ID: 10109718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast media in venous digital angiography: ionic or non-ionic?].
    Stacul F; Magnaldi S; Pozzi-Mucelli R; Muner G; Dalla Palma L
    Radiol Med; 1986 Nov; 72(11):815-22. PubMed ID: 3786845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of quality of care--can we afford it?
    Payne BC
    Forum Med; 1979 Apr; 2(4):297-9. PubMed ID: 10308855
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of outcome.
    Scott RS
    Adm Radiol; 1996 Jan; 15(1):38-9. PubMed ID: 10155049
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of gluconeogenesis and p-aminohipuric acid accumulation in rat renal cortical slices by ionic and nonionic contrast media.
    Nakamura M; Uozumi J; Soejima K; Kanou T; Tokuda N; Naito S
    Clin Exp Nephrol; 2003 Jun; 7(2):98-103. PubMed ID: 14586727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost vs safety. The use of low-osmolar contrast media.
    Fischer HW
    JAMA; 1988 Sep; 260(11):1614. PubMed ID: 3411743
    [No Abstract]   [Full Text] [Related]  

  • 16. Ionic vs. nonionic contrast media.
    Lloyd K
    Radiol Technol; 1994; 66(1):57-9. PubMed ID: 7997528
    [No Abstract]   [Full Text] [Related]  

  • 17. Economics. How much are human lives and health worth?
    Kaiser J
    Science; 2003 Mar; 299(5614):1836-7. PubMed ID: 12649460
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationing health care resources. Is the quality-adjusted life-year a helpful guide?
    Warren JM
    Can Fam Physician; 1994 Jan; 40():123-4, 127-8. PubMed ID: 8312748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation studies in nuclear medicine: a methodological review of the literature.
    Gambhir SS; Schwimmer J
    Q J Nucl Med; 2000 Jun; 44(2):121-37. PubMed ID: 10967623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.